Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis is crucial for effectively treating severe alopecia and related symptoms.

Blocking IL-17a can improve age-related smell loss in mice.

A rare lupus case on the chin was successfully treated with steroids and immunomodulators after accurate diagnosis using advanced imaging techniques.

Immune cells are crucial for normal skin development and their dysfunction can cause skin disorders.

A 16-year-old girl with autoimmune hemolytic anemia and deep vein thrombosis improved with treatment, possibly indicating systemic lupus erythematosus.

A tailored treatment improved a Pomeranian dog's skin and hair issues caused by a vaccine.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Skin issues might be linked to infertility.

Pregnancy-related skin disorders need accurate diagnosis and treatment to prevent risks to the baby.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Two microRNAs affect hair follicle development in sheep by targeting specific genes.

The treatment was ineffective in humans.

Working in non-Covid-19 wards and night shifts is linked to higher infection rates among Italian nurses.

Vaccination is the most effective way to reduce COVID-19 transmission.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Human hair keratins can self-assemble and support cell growth, useful for biomedical applications.

The document is a detailed medical reference on skin and genetic disorders.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Microneedle technology is effective for skin rejuvenation and enhancing cosmeceutical delivery, with ongoing innovation and increasing commercialization.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.